Jupiter Neurosciences Inc
JUNS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.27M
Close$
$-0.04
142.9% downside
Current Fair Value
142.9% downsideOvervalued by 142.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.27 Million |
|---|---|
| Enterprise Value | $5.74 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.25 |
| Beta | 1.71 |
| Outstanding Shares | 35,255,588 |
Return
| Return on Equity | 329.73% |
|---|---|
| Return on Assets | -232.44% |
| Return on Invested Capital | 324.32% |
Valuation & Multiples
| P/E Ratio | -0.33 |
|---|---|
| PEG | -0.95 |
| Price to Sales | - |
| Price to Book Ratio | -0.1 |
| Enterprise Value to Revenue | 141.95 |
| Enterprise Value to EBIT | -0.64 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.84 |
| Debt to Equity | -1.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$225,000
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$400,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.40%▲ 3.55% |
|---|---|
| Total Invested | $716,138▲ 9.90% |
| Investors Holding | 10▼ 2.00% |
ESG Score
No data